Investing Ideas
/
Dutch Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Dutch Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Lakefront Biotherapeutics

Market Cap: €1.8b

A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

LKFT

€26.64

1.1%

2.4%